Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to Praxedo and its founders on a growth LBO led by MBO & Co Bryan, Garnier & Co acts as Exclusive Financial Advisor to the shareholders and founders of kompany on the sale of the company to Moody’s Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of Sword GRC to Riskonnect, a portfolio company of TA Associates Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Aelis Farma’s Euronext Paris EUR 25m Initial Public Offering Bryan, Garnier & Co acts as Sole Financial Advisor to clinical-stage biologics company BiosanaPharma on its global strategic partnership with Alvotech Bryan, Garnier & Co acts as Sole Financial Advisor to Padoa and its shareholders on the investment of Five Arrows Growth Capital Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CyberCité, a SEO and SEA agency, on the sale of the Company to Isoskele, part of Groupe La Poste Bryan, Garnier & Co acts as Sole Financial Advisor to MNH on the sale of AKLIA to Hoppen Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue Bryan, Garnier & Co acts as Sole Financial Advisor to Wandercraft on its $45 million Fundraising Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CMN on its partnership with MBO & Co Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Headwall Photonics on the sale of the company to Arsenal Capital Partners
